ImmunomeInc Property Plant And Equipment Net from 2010 to 2024

IMNM Stock  USD 14.94  0.23  1.56%   
ImmunomeInc Property Plant And Equipment Net yearly trend continues to be very stable with very little volatility. Property Plant And Equipment Net is likely to drop to about 2 M. Property Plant And Equipment Net is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects ImmunomeInc's investment in assets used for production. View All Fundamentals
 
Property Plant And Equipment Net  
First Reported
2010-12-31
Previous Quarter
3.6 M
Current Value
M
Quarterly Volatility
621.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ImmunomeInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ImmunomeInc main balance sheet or income statement drivers, such as Net Interest Income of 2.9 M, Interest Income of 2.9 M or Depreciation And Amortization of 689.9 K, as well as many exotic indicators such as Price To Sales Ratio of 12.12, Dividend Yield of 0.0 or PTB Ratio of 1.86. ImmunomeInc financial statements analysis is a perfect complement when working with ImmunomeInc Valuation or Volatility modules.
  
This module can also supplement ImmunomeInc's financial leverage analysis and stock options assessment as well as various ImmunomeInc Technical models . Check out the analysis of ImmunomeInc Correlation against competitors.
To learn how to invest in ImmunomeInc Stock, please use our How to Invest in ImmunomeInc guide.

Latest ImmunomeInc's Property Plant And Equipment Net Growth Pattern

Below is the plot of the Property Plant And Equipment Net of ImmunomeInc over the last few years. It is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production. ImmunomeInc's Property Plant And Equipment Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ImmunomeInc's overall financial position and show how it may be relating to other accounts over time.
Property Plant And Equipment Net10 Years Trend
Pretty Stable
   Property Plant And Equipment Net   
       Timeline  

ImmunomeInc Property Plant And Equipment Net Regression Statistics

Arithmetic Mean1,960,033
Geometric Mean1,863,358
Coefficient Of Variation31.71
Mean Deviation371,884
Median2,082,000
Standard Deviation621,587
Sample Variance386.4B
Range2.8M
R-Value(0.11)
Mean Square Error410.9B
R-Squared0.01
Significance0.69
Slope(15,473)
Total Sum of Squares5.4T

ImmunomeInc Property Plant And Equipment Net History

2024M
20233.6 M
2022965 K
2021855 K
20201.5 M
20191.7 M

About ImmunomeInc Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include ImmunomeInc income statement, its balance sheet, and the statement of cash flows. ImmunomeInc investors use historical funamental indicators, such as ImmunomeInc's Property Plant And Equipment Net, to determine how well the company is positioned to perform in the future. Although ImmunomeInc investors may use each financial statement separately, they are all related. The changes in ImmunomeInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ImmunomeInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ImmunomeInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ImmunomeInc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Property Plant And Equipment Net3.6 MM

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as ImmunomeInc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether ImmunomeInc is a strong investment it is important to analyze ImmunomeInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ImmunomeInc's future performance. For an informed investment choice regarding ImmunomeInc Stock, refer to the following important reports:
Check out the analysis of ImmunomeInc Correlation against competitors.
To learn how to invest in ImmunomeInc Stock, please use our How to Invest in ImmunomeInc guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for ImmunomeInc Stock analysis

When running ImmunomeInc's price analysis, check to measure ImmunomeInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmunomeInc is operating at the current time. Most of ImmunomeInc's value examination focuses on studying past and present price action to predict the probability of ImmunomeInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmunomeInc's price. Additionally, you may evaluate how the addition of ImmunomeInc to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stocks Directory
Find actively traded stocks across global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Is ImmunomeInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmunomeInc. If investors know ImmunomeInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmunomeInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(17.58)
Revenue Per Share
0.427
Quarterly Revenue Growth
(0.56)
Return On Assets
(0.15)
Return On Equity
(1.55)
The market value of ImmunomeInc is measured differently than its book value, which is the value of ImmunomeInc that is recorded on the company's balance sheet. Investors also form their own opinion of ImmunomeInc's value that differs from its market value or its book value, called intrinsic value, which is ImmunomeInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmunomeInc's market value can be influenced by many factors that don't directly affect ImmunomeInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmunomeInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmunomeInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmunomeInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.